SCHEMBL6590845

SCHEMBL6590845

CC(C[CH]C(=O)N(Cc1cccs1)[C@H]1CCCNCC1=O)C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 1/20 0.35
NSD2 O96028 2/20 0.35
NSD3 Q9BZ95 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TRPM8 Q7Z2W7 2/20 0.35
HTT P42858 1/20 0.34
TP53 P04637 2/20 0.33
GAA P10253 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766714 0.85 GHSR (0.37)
SCHEMBL4936544 0.85 GHSR (0.37)
SCHEMBL4831656 0.82 PSEN1 (0.34) ALDH1A1
SCHEMBL6608111 0.82 SLC6A2 (0.40) ALDH1A1SMN1; SMN2
SCHEMBL6589898 0.82
SCHEMBL6593952 0.81 SLC6A2 (0.31)
SCHEMBL6590687 0.80 CXCR4 (0.32)
SCHEMBL6591064 0.79
SCHEMBL6595133 0.78 CCR2 (0.30)
SCHEMBL5099573 0.77 TRPM8 (0.34) TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP claimed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP claimed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO claimed
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP disclosed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO disclosed